Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $3.25, but opened at $3.43. Raia Drogasil shares last traded at $3.43, with a volume of 159 shares trading hands.
Raia Drogasil Stock Performance
The stock’s 50-day moving average is $3.56 and its 200-day moving average is $4.15.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05. The company had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, analysts expect that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
- Forget Chips: These 3 Stocks Are Building the AI Data Center Boom
- AIxCrypto Dumps Its Crypto and Goes All In on Robotics
- AST SpaceMobile’s FCC Test Arrives as Investors Weigh a Costly Q2 Miss
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
